- Home
- IVDA vs RDHL Comparison
IVDA vs RDHL Comparison
Compare IVDA & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- RDHL
- Stock Information
- Founded
- IVDA 2003
- RDHL 2009
- Country
- IVDA United States
- RDHL Israel
- Employees
- IVDA N/A
- RDHL N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- RDHL Health Care
- Exchange
- IVDA Nasdaq
- RDHL Nasdaq
- Market Cap
- IVDA 9.3M
- RDHL 8.6M
- IPO Year
- IVDA N/A
- RDHL N/A
- Fundamental
- Price
- IVDA $3.17
- RDHL $6.99
- Analyst Decision
- IVDA
- RDHL
- Analyst Count
- IVDA 0
- RDHL 0
- Target Price
- IVDA N/A
- RDHL N/A
- AVG Volume (30 Days)
- IVDA 598.8K
- RDHL 21.2K
- Earning Date
- IVDA 11-14-2024
- RDHL 12-27-2024
- Dividend Yield
- IVDA N/A
- RDHL N/A
- EPS Growth
- IVDA N/A
- RDHL N/A
- EPS
- IVDA N/A
- RDHL N/A
- Revenue
- IVDA $5,305,155.00
- RDHL $3,707,000.00
- Revenue This Year
- IVDA $23.76
- RDHL $224.90
- Revenue Next Year
- IVDA $229.89
- RDHL $82.69
- P/E Ratio
- IVDA N/A
- RDHL N/A
- Revenue Growth
- IVDA N/A
- RDHL N/A
- 52 Week Low
- IVDA $1.27
- RDHL $6.35
- 52 Week High
- IVDA $10.16
- RDHL $43.50
- Technical
- Relative Strength Index (RSI)
- IVDA 70.54
- RDHL 42.91
- Support Level
- IVDA $1.93
- RDHL $7.09
- Resistance Level
- IVDA $2.16
- RDHL $7.44
- Average True Range (ATR)
- IVDA 0.38
- RDHL 0.53
- MACD
- IVDA 0.14
- RDHL -0.03
- Stochastic Oscillator
- IVDA 65.45
- RDHL 12.36
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.